SEARCH

SEARCH BY CITATION

References

  • 1
    Halpin S, Hamlin PJ. Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis. Aliment Pharmacol Ther 2012; 35: 9578.
  • 2
    Rostholder E, Ahmed A, Cheifetz AS, Moss AC. Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis. Aliment Pharmacol Ther 2012; 35: 5627.
  • 3
    Seow CH, Newman A, Irwin SP, Steinhart AH, Silverberg MS, Greenberg GR. Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut 2010; 59: 4954.
  • 4
    Oussalah A, Evesque L, Laharie D, et al. A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization. Am J Gastroenterol 2010; 105: 261725.